Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Leisegang, Matthias Prof. Dr. rer. nat. (1) Pezzutto, Antonio Prof. Dr. (2) Uckert, Wolfgang Prof. Dr. (1) Willimsky, Gerald Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (10) (-) Selbach, Matthias Prof. Dr. (2) Biologie maligner Lymphome (2) Genetik und Genomik von Herz- Kreislauferkrankungen (1) (-) Molekulare Immunologie und Gentherapie (10) (-) Proteom Dynamik (2) Translationale Onkologie solider Tumore (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) (-) 1997 (9) 1998 (9) 1999 (4) 2000 (8) 2001 (8) 2002 (8) 2003 (10) 2004 (10) 2005 (14) (-) 2006 (3) 2007 (6) 2008 (8) 2009 (8) 2010 (10) 2012 (10) 2013 (15) 2014 (15) 2015 (13) 2018 (10) 2019 (11) 2020 (6) 2021 (16) 2022 (16) 2023 (9) 2024 (2) 12 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Selbach, Matthias Prof. Dr.Molekulare Immunologie und Gentherapie Proteom Dynamik19972006 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 16. März 2006 / Nature Robust Salmonella metabolism limits possibilities for new antimicrobials D. Becker M. Selbach C. Rollenhagen M. Ballmaier T.F. Meyer M. Mann D. Bumann 01. Dezember 2006 / Nat Methods Protein interaction screening by quantitative immunoprecipitation combined with knockdown (QUICK) M. Selbach M. Mann 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 15. Oktober 1997 / J Immunol Costimulatory signals through B7.1/CD28 prevent T cell apoptosis during target cell lysis P.T. Daniel A. Kroidl S. Cayeux R.C. Bargou T. Blankenstein B. Doerken 15. Juli 1997 / J Immunol Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte- macrophage colony-stimulating factor gene-modified tumor cells Z. Qin G. Noffz M. Mohaupt T. Blankenstein 01. Januar 1997 / Eur J Immunol Lack of correlation between rejection of tumor cells co-expressing interleukin 2 and B7.1 and vaccine efficiency S. Cayeux G. Richter C. Becker C. Beck A. Aicher A. Pezzutto B. Doerken T. Blankenstein 01. Januar 1997 / Exp Hematol Successful retroviral mediated transduction of a receptor gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells A. Aicher J. Westermann S. Cayeux G. Willimsky K. Daemen T. Blankenstein W. Uckert B. Doerken A. Pezzutto 01. Januar 1997 / Methods Mol Med Methods for use of cytokine gene-modified tumor cells in immunotherapy of cancer Z. Qin T. Blankenstein 01. Januar 1997 / J Immunol Influence of gene modified (IL 7, IL 4, and B7) tumor cell vaccines on tumor antigen presentation S. Cayeux G. Richter G. Noffz B. Doerken T. Blankenstein 01. Januar 1997 / Gene Ther Loss of retroviral gene expression in bone marrow reconstituted mice correlates with down regulation of gene expression in long term culture initiating cells C. Lange T. Blankenstein Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
16. März 2006 / Nature Robust Salmonella metabolism limits possibilities for new antimicrobials D. Becker M. Selbach C. Rollenhagen M. Ballmaier T.F. Meyer M. Mann D. Bumann
01. Dezember 2006 / Nat Methods Protein interaction screening by quantitative immunoprecipitation combined with knockdown (QUICK) M. Selbach M. Mann
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
15. Oktober 1997 / J Immunol Costimulatory signals through B7.1/CD28 prevent T cell apoptosis during target cell lysis P.T. Daniel A. Kroidl S. Cayeux R.C. Bargou T. Blankenstein B. Doerken
15. Juli 1997 / J Immunol Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte- macrophage colony-stimulating factor gene-modified tumor cells Z. Qin G. Noffz M. Mohaupt T. Blankenstein
01. Januar 1997 / Eur J Immunol Lack of correlation between rejection of tumor cells co-expressing interleukin 2 and B7.1 and vaccine efficiency S. Cayeux G. Richter C. Becker C. Beck A. Aicher A. Pezzutto B. Doerken T. Blankenstein
01. Januar 1997 / Exp Hematol Successful retroviral mediated transduction of a receptor gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells A. Aicher J. Westermann S. Cayeux G. Willimsky K. Daemen T. Blankenstein W. Uckert B. Doerken A. Pezzutto
01. Januar 1997 / Methods Mol Med Methods for use of cytokine gene-modified tumor cells in immunotherapy of cancer Z. Qin T. Blankenstein
01. Januar 1997 / J Immunol Influence of gene modified (IL 7, IL 4, and B7) tumor cell vaccines on tumor antigen presentation S. Cayeux G. Richter G. Noffz B. Doerken T. Blankenstein
01. Januar 1997 / Gene Ther Loss of retroviral gene expression in bone marrow reconstituted mice correlates with down regulation of gene expression in long term culture initiating cells C. Lange T. Blankenstein